Latest News about TAK
Recent news which mentions TAK
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
Moderna Japan Scare Might Offer a Small Lift to Still-Alive Novavax Stock
September 02, 2021
From InvestorPlace
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
September 01, 2021
From Benzinga
From Benzinga
From Benzinga
Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
Takeda To Lead Finch-Partnered Microbiome IBD Drug
August 10, 2021
From Benzinga
Why BioCryst Pharmaceuticals Rose 8% on Thursday
August 05, 2021
From Motley Fool
Analyzing Takeda Pharmaceutical's Unusual Options Activity
August 03, 2021
Tickers
TAK
From Benzinga
From Benzinga
From InvestorPlace
Is It Too Late to Buy Novavax Stock?
July 26, 2021
From Motley Fool
XBIO Stock: Xenetic Soars on Takeda Expansion News
July 23, 2021
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.